subcutaneous injection semaglutide Mechanism of Action: A Comprehensive Guide Understanding Semaglutide: Boosting Metabolism &

Ozempic is FDA-approved for type 2 diabetes

Rare Thyroid Cancer Risks: Semaglutide carries a warning regarding thyroid tumors, though this risk is rare

At 72 weeks, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide

Constipationdefined as having fewer than three bowel movements per week, hard or dry stools, or difficulty or pain with passage of stoolis a recognized adverse effect of GLP-1 receptor agonists, though it occurs less frequently than nausea or diarrhea

Front Endocrinol

Ultraviolet light is the worst offender, but even normal indoor lighting contributes to breakdown over time